According to results of an early study conducted in the U.S., the one-time vaccine of Johnson&Johnson could potentially protect people against Delta strain of coronavirus. ABC News reported that as saying.
The conclusions of this study are preliminary but perspective. Researchers analyzed the blood samples of 10 people vaccinated with Johnson&Johnson and then had them tested against several strains, including Delta. It appears that the vaccine works against the new variants; anti-bodies dilution points out to the powerful immune reaction.
"Today's newly announced studies reinforce the ability of the Johnson & Johnson COVID-19 vaccine to help protect the health of people globally," said Dr. Paul Stoffels, vice chairman of the executive committee and chief scientific officer at Johnson & Johnson; the outlet cited him as saying.
"Prior data has indicated that other vaccines, including those made by Pfizer and Moderna, are likely to hold up against the delta variant. But some experts worried the Johnson & Johnson vaccine, which unlike the others, only includes one dose, might not fare as well", ABC News concluded.